acrolein has been researched along with p-hydroxycinnamaldehyde in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, JO; Hong, JT; Jung, JK; Lee, CW; Lee, JW; Lee, SH; Lee, SY; Moon, DC; Oh, KW; Yoo, HS | 1 |
| Bradshaw, TD; Chua, YS; Franks, M; Gan, FF; Hagen, T; Palaniappan, P; Poobalasingam, T; Scarmagnani, S; Westwell, AD | 1 |
| Chang, H; Hong, SH; Ismail, IA; Kang, HS; Kim, HS; Kim, NH; Kwon, BM; Lee, CW; Lee, HJ; Yook, JI; Yun, J | 1 |
| Chen, L; Cui, WX; Ma, M; Shan, BE; Shan, YN; Yang, XX; Zhao, LM | 1 |
| Chang, JH; Jeong, H; Kang, SG; Kim, HS; Kim, NH; Lee, JE; Park, J; Shim, JK; Yook, JI | 1 |
5 other study(ies) available for acrolein and p-hydroxycinnamaldehyde
| Article | Year |
|---|---|
2-hydroxycinnamaldehyde inhibits SW620 colon cancer cell growth through AP-1 inactivation.
Topics: Acrolein; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Growth Inhibitors; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Luciferases; Molecular Structure; Oligonucleotides; Protein Binding; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Structure-Activity Relationship; Transcription Factor AP-1; Transfection | 2007 |
Structure-activity analysis of 2'-modified cinnamaldehyde analogues as potential anticancer agents.
Topics: Acrolein; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzoates; Cell Line, Tumor; Cinnamates; Drug Design; Humans; Proteasome Endopeptidase Complex; Structure-Activity Relationship | 2009 |
2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
Topics: Acrolein; Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Cinnamates; Disease Models, Animal; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; MCF-7 Cells; Mice; Neoplasm Metastasis; Snail Family Transcription Factors; Transcription Factors; Transcriptional Activation; Wnt Signaling Pathway | 2013 |
p-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway.
Topics: Acrolein; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cinnamates; Cyclic AMP; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Humans; MAP Kinase Signaling System; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; rhoA GTP-Binding Protein | 2016 |
Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Topics: Acrolein; Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzoates; Cell Line, Tumor; Cell Survival; Cinnamates; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Temozolomide; Tissue Scaffolds | 2019 |